Results 91 to 100 of about 43,372 (134)

Intestinal Epithelial Memory: From Inflammatory Imprinting to Metabolite‐Shaped Immune Tolerance

Barrier Immunity, Volume 2, Issue 3, Page 119-130, September 2026.
ABSTRACT Intestinal epithelial cells are rapidly renewing barrier cells that maintain compartmentalization between the luminal environment and the mucosal immune system through epithelial transport, antimicrobial defense, secretory programs, and cytokine‐mediated communication.
Wenjing Yang, Tianming Yu, Yingzi Cong
wiley   +1 more source

SLC3A1 Mitigates Ferroptosis and Promotes Enzalutamide Resistance in Prostate Cancer

Journal of Biochemical and Molecular Toxicology, Volume 40, Issue 9, September 2026.
SLC3A1 is a promising therapeutic target for advanced prostate cancer. ABSTRACT Prostate cancer (PCa) remains a leading cause of cancer‐related mortality in aging male, with resistance to enzalutamide (Enza) representing a major therapeutic challenge. This study identifies SLC3A1 as a key driver of Enza resistance.
Peng Liu, Haocheng Zhang, Yuhang Qian, Jiong Zhang, Xiaojun Deng, Bin Sun   +5 more
wiley   +1 more source

Efficacy of Interleukin‐12/23 and Interleukin‐23 Inhibitors for Moderately to Severely Active Crohn's Disease in Advanced Treatment Failure Populations: Systematic Review and Network Meta‐Analysis

JCC Plus, Volume 1, Issue 5, September 2026.
ABSTRACT Background and Aims Earlier trials of advanced treatments indicated for moderately to severely active Crohn's disease used predominantly re‐randomized induction responder designs, whereas newer treatments were evaluated using treat‐through designs.
Christopher Ma, Marla Dubinsky, Gil Y. Melmed, Namita Joshi, Jenny Griffith, Fernando Aponte, Brooke Kim, Eric B. Collins, Kristen Westerhoff, Remo Panaccione   +9 more
wiley   +1 more source

Rational Monitoring of Patients With Inflammatory Bowel Disease in Remission: Results From the Danish DK‐MONITOR Delphi Consensus Study

JCC Plus, Volume 1, Issue 5, September 2026.
ABSTRACT Background Monitoring strategies for patients with inflammatory bowel disease (IBD) in remission vary widely in clinical practice, reflecting limited evidence and a lack of consensus. With increasing numbers of patients living long term with IBD, there is a need for rational, clinically meaningful approaches to remission‐phase monitoring ...
Johan Burisch, Jakob B. Seidelin, Marianne Kajbæk Vester‐Andersen, Signe Wildt, Klaus Theede, Else Kjær Mikkelsen, Anders Lødrup, Mette Esbjørn, Pernille Larsen, Dorte Vind Andersen, Charlotte Riddersholm, Ulrich Martin Bick, Christiane Bro Simonsen, Lone Trier Kronkjær, Rikke Edelbo, Anders Dige, Jørgen Agnholt, Anne‐Mette Haase, Lars Koch Hansen, Anne Louise Brix Nørgaard, Osama Karim Abed, Heidi Ivarsen, Stine Hald, Charlotte Teglgaard, Christina Rasmussen, Eva Fjordside, Ebbe Langholz, Pia Berg, Torben Nathan, Rune Wilkens, Julie Gaardbo, Vladimir Gancho, Christina Juul de Blanck, Tina Weien Kristensen, Julie Rasmussen, Signe Wiese, Magid Al‐Khalaf, Atef Kinani, Charlotte Sørensen, Anja Poulsen, Torben Knudsen, Lone Larsen, Jens Kjeldsen   +42 more
wiley   +1 more source

Neoplasias mamárias em cadelas e gatas

, 2009
Dissertação de Mestrado Integrado em Medicina VeterináriaO estudo das neoplasias mamárias tem um elevado interesse clínico e científico pois além de constituírem uma das neoplasias mais frequentes nas cadelas e nas gatas, muitos dos resultados obtidos ...
Pinto, Rita Mafalda Marques de Oliveira
core   +2 more sources

The Evolution of Medications for Obesity Management

JGH Open, Volume 10, Issue 9, September 2026.
ABSTRACT This narrative review provides an overview of progress in the development of obesity medications, including a synthesis of data describing the efficacy and safety of currently available agents and emerging therapeutic options. Historically, many obesity medications have been withdrawn from the market due to safety concerns.
Jaskirath Gill, Priya Sumithran
wiley   +1 more source

Lípidos y neoplasias

, 1991
Se comparan en este estudio los perfiles lipídicos de una población normal de 100 personas con los de 111 afectados de neoplasias diversas. En todos los casos se trataba exclusivamente de varones.
Fernández Rippe, Mª Luisa
core  

Tissue‐Resident Macrophage in Inflammation and Cancer

MedComm, Volume 7, Issue 9, September 2026.
Opposing macrophage functions in inflammation and cancer converge on shared mechanistic nodes, informing cross‐disease therapeutic strategies. ABSTRACT Tissue‐resident macrophages (TRMs) are long‐lived immune cells strategically distributed across organs, where their functional plasticity enables both homeostatic maintenance and pathological ...
Siyuan Huang, Jiangbo Fan, Wenyi Liu, Di Liu, Rui Wang, Yuanyang Wang, Jianhui Sun, Huacai Zhang, Qingli Cai, Zhe Xu, Fang Xu, Jianxin Jiang, Zhen Wang, Ling Zeng   +13 more
wiley   +1 more source

Plasticité et reprogrammation des cellules intestinales

, 2009
Les cellules endocrines pancréatiques et intestinales partagent de nombreuses caractéristiques moléculaires, cellulaires et fonctionnelles.Particulièrement, leur différenciation repose sur des programmes génétiques similaires contrôlés par le facteur de ...
GRADWOHL, Gérard, BEUCHER, Anthony
core  

Prostate Cancer Development, Progression, and Therapy

MedComm – Oncology, Volume 5, Issue 3, September 2026.
This review provides an integrated overview of prostate cancer development, progression, and therapy, spanning historical milestones, molecular mechanisms, advanced research models, and emerging therapeutic strategies. It highlights recent advances in precision diagnosis, lineage plasticity, therapy resistance, and next‐generation treatments for ...
Xin Jin, Zicheng Xiao, Zexian Ding, Wei Li, Ruijiang Zeng, Yujun Shuai, Weimin Ci, Dan Xia, Xu Zhang, Haojie Huang   +9 more
wiley   +1 more source